Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1100_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Contributors
- •Part I
- •Esophageal Surgery
- •Tracheo-Esophageal Fistula
- •Overview
- •Etiology
- •Clinical Presentation
- •Diagnosis
- •Management
- •Conservative Management
- •Endoscopic Management
- •Operative Management
- •Postesophagectomy TEF
- •Postintubation TEF
- •Bronchoesophageal Fistula
- •Prevention of Tracheoesophageal Fistula
- •Outcomes
- •Conclusion
- •Five Key Points to Avoid Complications
- •Five Key Points to Diagnose or Manage Complications Intra or Postoperatively
- •References
- •Esophageal Strictures Refractory to Endoscopic Dilatation
- •Introduction
- •Etiology of Esophageal Strictures
- •Treatment
- •Treatment of Benign Esophageal Strictures
- •Nonsurgical Options
- •Endoscopic Dilatation
- •Steroid Injection
- •Esophageal Stenting
- •Rendez-Vous Procedure
- •Incisional Therapy
- •Surgical Options
- •Antireflux Surgery for Peptic Strictures
- •Esophagectomy
- •Malignant Esophageal Strictures
- •Endoscopic Treatment
- •Dilatation
- •Stent Placement
- •Laser Therapy
- •Brachytherapy
- •Chemotherapy and Radiation Therapy
- •Surgical Treatment
- •Conclusion
- •Key Points for Avoiding Postsurgical Esophageal Strictures
- •Key Points for Managing Esophageal Strictures
- •References
- •Esophageal Anastomotic Leak
- •Introduction
- •Risk Factors for Anastomotic Leak
- •Presentation and Identification of a Leak
- •Prevention and Management of Anastomotic Leaks
- •Future Directions
- •Conclusion
- •Key Points on Avoiding an Esophageal Anastomotic Leak
- •Key Points on Diagnosis and Managing an Esophageal Anastomotic Leak
- •References
- •Transhiatal Esophagectomy—Intraoperative Disasters
- •Introduction
- •Preoperative Risk Factors for Bleeding with a THE
- •General Considerations
- •Anesthetic Considerations
- •Conduct of the Operation
- •Bleeding Scenarios During THE
- •Tracheal Tear
- •Summary
- •Key Points: Avoiding Catastrophic Complications—Mediastinal Bleeding and Airway Injury—During Transhiatal Esophagectomy
- •Key Points: Diagnosing and Managing Catastrophic Complications—Mediastinal Bleeding and Airway Injury—During Transhiatal Esophagectomy
- •References
- •Chyle Leak After Esophageal Surgery
- •Introduction
- •Historical Review
- •Basic Science
- •Embryology
- •Anatomy
- •Physiology
- •Composition of Chyle
- •Chylothorax
- •Etiology/Cause
- •Post-esophagectomy Chylothorax
- •Diagnosis
- •Clinical Features
- •Fluid Studies
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Summary
- •Key Points on Avoiding an Esophageal Anastomotic Leak
- •Key Points on Diagnosis and Managing an Esophageal Anastomotic Leak
- •References
- •Evaluation of the Vocal Cords
- •Treatment of Unilateral Vocal Cord Dysfunction
- •Injection Augmentation
- •Framework Surgery for Unilateral Vocal Cord Dysfunction
- •Treatment of Bilateral Vocal Paralysis
- •Key Summary Points
- •References
- •Introduction
- •Pathophysiology
- •Classification
- •Symptoms
- •Diagnosis
- •Management of Airway, Hoarseness, and Vocal Cord Dysfunction After Esophagectomy
- •Introduction
- •Vocal Fold Dysfunction
- •Symptoms of Unilateral Vocal Cord Dysfunction
- •Symptoms of Bilateral Vocal Cord Dysfunction
- •Treatment
- •Complications
- •Conclusion
- •Five Key Points on How to Avoid Complications
- •Five Key Points on Diagnosing and/or Managing the Complications Either Intraoperatively or Postoperatively
- •References
- •Intraoperative Solutions for the Gastric Conduit that Will Not Reach
- •Colon as an Alternative Conduit
- •Jejunum as an Alternative Conduit
- •Pedicled Jejunal Interposition
- •Free Jejunal Interposition
- •Summary
- •Key Points
- •References
- •Injury to the Right Gastroepiploic Artery
- •Introduction
- •Anatomy of the RGEA
- •Vascular Considerations in Esophagectomy
- •Preoperative Evaluation of the RGEA
- •Preparation and Mobilization of the Gastric Conduit
- •Techniques for Improving Tissue Oxygenation
- •Tension-Free Anastomosis
- •“Supercharging”
- •Venous Drainage
- •Conclusion
- •Five Key Points: Avoiding Injury to the Right Gastroepiploic Artery
- •References
- •Intra-Operative Solutions for Ischemic Gastric Conduit
- •Gastric Esophageal Replacement Conduit
- •Diagnosis of Gastric Conduit Ischemia
- •Summary
- •Key Points for Avoiding Gastric Conduit Necrosis
- •Key Points for Managing Gastric Conduit Necrosis Postoperatively
- •References
- •Jejunal Feeding Tube Complications
- •Introduction
- •Technique for Placement
- •Open Surgical Jejunostomy Tubes
- •Laparoscopic Jejunostomy Tubes
- •Complications
- •Bowel Necrosis
- •Bowel Obstruction
- •Tube Dysfunction
- •Infectious Complications
- •Aspiration
- •Conclusion
- •Key Points
- •References
- •Part II
- •Gastric Surgery
- •Gastroparesis
- •Etiology
- •Clinical Presentation and Evaluation
- •Management
- •Bile Reflux
- •Etiology
- •Clinical Presentation and Evaluation
- •Management
- •Conclusion
- •Key Points (Prevention)
- •Key Points (Management)
- •References
- •Dealing with Dumping Syndrome
- •Introduction
- •Diagnosis
- •Prevention
- •Management of Dumping Syndrome
- •Diet
- •Pharmacologic Therapy
- •Acarbose
- •Somatostatin Analogs
- •Studies of the Fast-Acting Somatostatin Analog Octreotide
- •Studies of Long-Acting Octreotide LAR
- •Adverse Effects of Somatostatin Analogs
- •Surgical Treatment
- •Conversion of Billroth II to Billroth I Anastomosis
- •Roux-en-Y Conversion
- •Continuous Enteral Feeding
- •Conclusion
- •Key Points
- •References
- •Introduction
- •Epidemiology
- •Etiology
- •Pathophysiology
- •Clinical History
- •Physical Findings
- •Differential Diagnosis
- •Diagnosis
- •Noninvasive Imaging Studies
- •Treatment
- •Medical Treatment
- •Endoscopic/Interventional Radiology
- •Surgical Intervention
- •Summary
- •Key Points for Avoiding
- •Key Points for Diagnosing/Managing
- •References
- •Duodenal Stump Blowout
- •Introduction
- •Clinical Presentation of Blowout
- •Mechanisms Contributing to Blowout
- •Staple Line Failure
- •Distal Obstruction
- •Malnutrition
- •The Difficult Duodenum
- •Techniques for Reducing the Risk of Blowout
- •Management of the Difficult Duodenum
- •General Principles of Closure
- •Nissen Technique
- •Bancroft Technique
- •Tube Duodenostomy and Drainage
- •Management of Stump Blowout
- •Medical Management
- •Percutaneous Radiologic Techniques
- •The Decision to Operate and Surgical Approach
- •Summary of Management
- •Ramifications of Blowout
- •Conclusions
- •Key Points: Avoiding Duodenal Stump Blowout
- •Key Points: Diagnosing and Managing Stump Blowout
- •References
- •Postoperative Complications After Surgery for Gastric Cancer: Anastomotic Leakage
- •Introduction
- •Incidence
- •Prospective Factors
- •Detection
- •Differential Diagnosis
- •General Management
- •External Drainage
- •Treatment of the Leakage Site
- •Duodenal Stump Leakage
- •Summary
- •Five Key Points to Avoid Anastomotic Leakage
- •Five Key Points to Diagnose and Manage Leakage
- •References
- •Part III
- •Hepatobiliary and Pancreatic Surgery
- •Introduction
- •Definition of PHI
- •Risk Factors for PHI
- •Prevention of PHI
- •Systematic Volumetry of the “Fully Functioning” Part of the Liver
- •Portal Vein Embolization
- •Limiting the Duration of Preoperative Chemotherapy
- •Treatment of PHI
- •Conclusion
- •Key Points
- •References
- •Biliary Leaks and Thoracobiliary Fistula
- •Introduction
- •Definitions
- •Biliary Leak and Grading System
- •Controlled and Uncontrolled Biliary Leaks
- •Source
- •Risk Factors and Prevention
- •Prevention
- •Risk Factors for Bile Leaks After Extrahepatic Bilioenteric Anastomosis
- •Prevention
- •Risk Factors for Bile Leak After Liver Resection
- •Prevention of Biliary Leaks After Hepatectomy
- •Intraoperative Tests for Bile Leaks
- •Postoperative Drains
- •Diagnosis
- •Investigations
- •Ultrasonography or CT Scan
- •Fistulogram
- •MRC, ERC, and PTC
- •HIDA
- •Management
- •Medical Management
- •Endoscopic Management
- •Interventional Radiology
- •Combined Endoscopic and Interventional Radiology Approaches—Rendezvous Procedures
- •Thoracobiliary Fistula
- •Diagnosis
- •Treatment
- •Five Key Points to Avoid Complications
- •Five Key Points to Diagnosis or Manage Complications
- •References
- •Contralateral Bile Duct Injury During Hepatic Resection
- •Introduction
- •Etiology and Risk Factors
- •Anatomical Variations
- •Difficult Surgical Resection and Reoperation
- •Type of Liver Resection
- •Aggressive Dissection and Devascularization of Bile Ducts
- •Initial Investigations and Management
- •Initial Investigations
- •Stabilization and Operative Planning
- •No Evidence of Distal Obstruction with Fistula
- •Evidence of Distal Obstruction with Fistula
- •Evidence of Distal Obstruction but no Fistula
- •Definitive Management
- •Anatomy Relevant to Operative Repair of Biliary Outflow of Remnant
- •Operative Repair
- •Repair of Injury to Right Liver Outflow
- •Repair of Injury to Left Liver Outflow
- •Prevention of Contralateral Bile Duct Injury
- •Attention to Variation in Biliary
- •Intrahepatic Control of Biliary Radicals
- •Tumor Close to the Hilum
- •Outcomes
- •Five Key Points to Avoid Contralateral Bile Duct Injury
- •Five Key Points to Diagnose and Treat Contralateral Bile Duct Injury
- •References
- •Massive Intraoperative Hemorrhage During Hepato-Biliary and Pancreatic Surgery
- •Introduction
- •Hemorrhage During Liver Surgery
- •Magnitude of Problem
- •Hepatic Vascular Anatomy
- •Prevention of Major Hemorrhage During Hepatic Resection
- •Techniques Aimed at Reducing Blood Loss During Hepatic Surgery
- •Deliberate Dissection and Exposure of Retro-Hepatic Vena Cava and Major Hepatic Veins
- •Hepatic Inflow Control
- •Vascular Isolation
- •Acute Normovolemic Hemodilution (ANH)
- •Management of Intra-Operating Bleeding During Liver Resection
- •Massive Hemorrhage During Pancreatic Surgery
- •Pancreatic Anatomy
- •Bleeding During Pancreaticoduodenectomy
- •Summary
- •5 Key Points to Avoid Complications
- •References
- •Intraoperative Injury to Hepatic Arterial Structures
- •Introduction
- •Normal Anatomy of the Hepatic Arterial Vasculature
- •Variant Anatomy of the Hepatic Arterial Vasculature
- •Replaced and Accessory Right Hepatic Arteries
- •Replaced and Accessory Left Hepatic Arteries
- •Replaced Common Hepatic Artery
- •Celiac Artery Stenosis
- •Preoperative Radiographic Assessment
- •Preoperative Considerations
- •Intraoperative Considerations
- •Specific Intraoperative Considerations
- •Pancreaticoduodenectomy (PD)
- •Replaced/Accessory Right Hepatic Artery
- •Replaced Common Hepatic Artery
- •Celiac Artery Stenosis
- •Hemi-hepatectomy
- •Conclusions
- •Key Points: Preoperative Interventions
- •Key Points: Intraoperative Principles
- •References
- •Hepatic Abscess
- •Etiology
- •Diagnosis
- •Computed Tomography
- •Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Five Key Points on How to Avoid Complications
- •Five Separate Key Points on Diagnosing and/or Managing the Complication
- •References
- •Hepaticojejunostomy Anastomotic Strictures
- •Introduction
- •Diagnosis
- •Clinical and Biological Presentation
- •Morphological Evaluation
- •Incidence and Risk Factors According to the Clinical Context
- •Iatrogenic Bile Duct Injury
- •Liver Transplantation (LT)
- •Pancreatic Head Resection
- •Choledochal Cyst
- •Therapeutic Options
- •Conservative Management
- •Choice of the Approach
- •To Stent or Not to Stent?
- •Periprocedural Management
- •Surgery
- •Revisionary Surgery
- •Liver Resection
- •Liver Transplantation (LT)
- •Key Points: How to Avoid HJ Stricture
- •Key Points: Diagnostic and Management
- •References
- •Defining Pancreatico-Jejunostomy Strictures (PJS) and Pancreatico-Jejunostomy Strictures (PGS) by Symptoms, Morphology and Function
- •Management of Intractable Pain Due to PJA or PGS Stenosis in Surgical Case Series
- •Endoscopic Techniques for Management of PJA Strictures
- •Technical Clinical Results for ERP
- •EUS-Guided Access and Drainage
- •EUS-Guided Rendezvous
- •Pancreatic Antegrade Needle Knife (PANK) Technique
- •EUS-Guided Pancreatogastrostomy
- •Jejunal Stenosis Mimicking PJA Stenosis
- •Conclusions
- •Key Points
- •References
- •Postoperative Portal, Mesenteric, and Splenic Vein Thrombosis
- •Introduction
- •Pathophysiology
- •Diagnosis: Clinical Manifestations and Blood Tests
- •Diagnosis: Imaging Tests
- •Treatment
- •Anticoagulation
- •Interventional Techniques
- •Surgery
- •Conclusion
- •Key Points for Diagnosis
- •Key Points for Treatment
- •References
- •Postpancreatectomy Hemorrhage: Early and Late
- •Introduction
- •Prevention of Late PPH
- •The Falciform Ligament
- •The Portal Dissection
- •GDA Ligation
- •Reinforcing the Pancreatic Transection Site (Distal Pancreatectomy)
- •Diagnosis of Late PPH
- •Symptoms/Signs
- •Imaging for Late PPH
- •Management of PPH
- •Early PPH
- •Late PPH
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points to Diagnose/Manage
- •References
- •Major Disruptions of Pancreaticojejunostomy
- •Introduction
- •Conclusion
- •Key Points: How to Avoid Complications
- •Key Points: Diagnosis/Management
- •References
- •Persistent Pancreatic Fistula
- •Introduction
- •Definition of Pancreatic Fistula
- •Procedure-Specific Incidence and Risk Factors for Pancreatic Fistula
- •Pancreaticoduodenectomy
- •Distal Pancretectomy
- •Duodenum-Preserving Pancreatic Head Resection/Lateral Pancreaticojejunostomy
- •Pancreatic Pseudocyst Drainage/Pancreatic Necrosectomy
- •Other Pancreatic Resections
- •Prevention of Pancreatic Fistula
- •Complications of Pancreatic Fistula
- •Management of Pancreatic Fistula
- •Initial Management
- •Delineation of Pancreatic Duct
- •Definitive Treatment of Pancreatic Fistula
- •Operative Management of Pancreatic Fistula
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points: Diagnosing and/or Managing Complications Either Intra- or Postoperatively
- •References
- •Management of Chyle Leaks Following Pancreatic Resection
- •Introduction
- •Background
- •Anatomy and Physiology of Visceral Lymphatics
- •Diagnosis of a Chyle Leak
- •Management of a Chyle Leak
- •The Contained Chyle Leak
- •Chylous Ascites
- •Management of Refractory Chyle Leaks
- •Conclusion
- •Key Points in Managing a Chyle Leak
- •References
- •Overview
- •Diagnosis
- •Prevention
- •Identifying Risk Factors
- •Role of Octreotide
- •Role of Pancreatic Stenting
- •Dissection and Management of the Pancreatic Stump
- •Minimally Invasive Versus Open Techniques
- •Drain Placement and Management
- •Management of Complications of Pancreatic Leak
- •Goal-Directed Resuscitation and Infection Control
- •Further Definition of Anatomy and Source Control
- •Optimizing Patient Clinical Status for Ongoing Conservative Management
- •Deliberate Reintervention When Clinically Indicated
- •Summary
- •Key Points on Avoiding Complications
- •Key Points on Diagnosis/Management of Complications
- •References
- •Part IV
- •Colorectal Surgery
- •Pearls for the Small Bowel and Colon That Will Not Reach
- •Introduction
- •Anatomic Constraints
- •Diagnosing the Problem
- •Specific Techniques: Making It Reach
- •Colorectal and Coloanal Anastomosis
- •Lateral-to-Medial Approach
- •Medial-to-Lateral Approach
- •Ileal-Pouch Anal Anastomosis (IPAA)
- •Stomas that Do Not Reach
- •Bailout Maneuvers—It Just Does Not Reach
- •Conclusions
- •Key Points on How to Avoid the Complication
- •Key Points on Diagnosing/Managing the Complication
- •References
- •Anastomotic Leak/Pelvic Abscess
- •Introduction
- •Prevention
- •Diagnosis and Management
- •Diagnosis
- •Management
- •Type I: Generalized Peritonitis
- •Type II: Localized Pelvic Abscess
- •Type III: Fistula
- •Long-Term Outcome
- •Need for a Permanent Stoma
- •Stenosis or Stricture
- •Local Recurrence
- •References
- •Management of Anastomotic Stricture
- •Introduction
- •Etiology of Anastomotic Stricture
- •Presentation and Diagnosis
- •Nonoperative Treatment
- •Balloon Dilation and Endoscopic Options
- •Stents
- •Operative Treatment
- •Reoperative Surgery
- •Anastomotic Revision and Diverting Stomas
- •New Technology
- •Conclusion
- •To Avoid Anastomotic Strictures in Colorectal Resections
- •Five Points on Diagnosing and Managing Anastomotic Strictures
- •References
- •Intraoperative Ureteral Injury
- •Introduction
- •Role of Preoperative Stenting
- •Incidence of Ureteric Injury and Early Identification of Injury
- •Placement of Ureteral Stents
- •Detection of Ureter Injury
- •Management of Ureter Injury
- •Proximal Third Injuries
- •Middle Third Ureteral Injuries
- •Lower Third Ureteral Injuries
- •Delayed Ureteral Transection or Ligation
- •Management Post Repair
- •Outcomes
- •Key Points to Avoiding Injury
- •Key Points to Diagnosis and Manage the Complication
- •References
- •Introduction
- •Anatomy
- •Incidence
- •Types of Prostatic Urethral Injury
- •Prevention
- •Detection
- •Management
- •Delayed Rectourethral Fistula
- •Conclusion
- •Key Points on Avoiding Complications
- •Key Points on Diagnosing/Managing Prostatic Urethral Injuries
- •References
- •Vaginal Injury During Stapled Anastomosis
- •Introduction
- •How to Avoid Vaginal Injury
- •How to Fix Vaginal Injury
- •Key Points on How to Avoid Vaginal Injury
- •Management of Rectovaginal Fistula
- •Introduction
- •General Principles
- •Local Repair
- •Mucosal Advancement Flap Repair
- •Endorectal Advancement Flap with Muscular Plication (Anterior Levatorplasty)
- •Transanal Sleeve Advancement Flap
- •Transvaginal Repair
- •Fistulotomy
- •Ligation of Intersphincteric FistulaTract
- •Biological Agents: Fibrin Glue and Fistula Plug
- •Miscellaneous
- •Tissue Transfer Procedures
- •Gracilis Muscle Interposition Flap
- •Martius Flap
- •Abdominal Procedure
- •Transperineal Omental Flap
- •Perioperative Management
- •Conclusion
- •Key Points to Avoid Complications
- •Key Points on Diagnosis and/or Managing Complications
- •References
- •Management of Presacral/Pelvic Bleeding
- •Introduction
- •Anatomy
- •Patterns of Injury
- •Management
- •Role of the Anaesthesiologist
- •Role of the Surgeon
- •Minimal-Access Surgery
- •The Postoperative Period
- •Summary
- •Key Points
- •References
- •Introduction
- •Preoperative Evaluation
- •Medical Comorbidities
- •Radiation Therapy
- •Chemotherapy
- •Imaging
- •Timing of Reconstruction
- •Classification of Defect
- •Reconstructive Surgical Tenants
- •Adjuncts to Flap Surgery
- •Negative Pressure Wound Therapy
- •Tissue Expansion
- •Biologic Tissue Matrices
- •Rectus Abdominis Muscle
- •Gracilis Muscle Flap
- •Gluteus Maximus Muscle
- •Pudendal Flap
- •Anteriolateral Thigh Flap
- •Postoperative Care
- •Ambulation
- •Drain Management
- •Complications
- •Summary
- •Key Points: Preventing Complications
- •Key Points: Managing Complications
- •References
- •Complications After TEM (Transanal Endoscopic Microsurgery) and TAMIS (Transanal Minimally Invasive Surgery)
- •Background
- •Complications of TEM and TAMIS
- •Postoperative Fever
- •Wound Dehiscence
- •Rectal Pain
- •Peritoneal Perforation
- •Pelvic Phlegmon and Abscess
- •Fistula
- •Bleeding
- •Incontinence
- •Conclusion
- •Key Points: Avoiding a Complication
- •Key Points: Managing/Diagnosing Septic Complications
- •References
- •Parastomal Hernia
- •Overview
- •Definition and Classification
- •Incidence
- •Pathophysiology
- •Risk Factors
- •Complications
- •Prevention
- •Preoperative Considerations
- •Operative Considerations
- •Diagnosis
- •History and Physical Exam
- •Imaging
- •Management
- •Nonoperative Management
- •Operative Management
- •Open Approach
- •Laparoscopic Approach
- •Postoperative Complications
- •Management of Recurrent Parastomal Hernias
- •Key Points: Diagnosing/Managing Parastomal Hernia
- •Key Points: Avoiding Parastomal Hernia Complications
- •References
- •Stoma Retraction/Ischemia/Stenosis
- •Introduction
- •Etiology/Incidence/Risk Factors
- •Prevention
- •Recognition/Assessment/Severity/Therapy
- •Conclusions
- •Five Keys Points in Diagnosing and Managing Stenosis, Retraction, and Ischemia in an Ostomy
- •Five Key Points on How to Avoid Tension and Ischemia in an Ostomy
- •References
- •Incontinence After Lateral Internal Sphincterotomy/Fistulotomy
- •Introduction
- •Lateral Internal Sphincterotomy
- •Fistulotomy
- •Management
- •Evaluation
- •Treatment
- •Injectables
- •Magnetic Bowel Sphincter
- •Sacral Nerve Stimulator
- •Artificial Bowel Sphincter
- •Diversion
- •Key Points: Strategies to Avoid the Complication of Incontinence
- •Key Points: Diagnosing and/or Managing the Complication of Incontinence Either Intraoperatively or Postoperatively
- •References
- •Anal Stenosis After Hemorrhoidectomy: Avoidance and Management
- •Introduction
- •Diagnosis
- •Classification of Stenosis
- •Treatment
- •Prevention
- •Nonoperative Intervention
- •Operative Intervention
- •Anatomic Versus Functional Stenoses
- •Preoperative Planning
- •Postoperative Care
- •Summary
- •Key Points: Managing Complications
- •References
- •Part V
- •Other Considerations
- •Delivering Bad News: Conversations with My Surgeon
- •Introduction
- •Informed Consent
- •The Family Does Not Want the Patient to be Fully Informed
- •Perioperative Death
- •When an Intraoperative Death Does Occur
- •Discussion of Unresectability or Metastatic Disease that Precludes Resection
- •Discussion of a Postoperative Complication
- •Discussion of the Unanticipated Major Postoperative Complication
- •Discussion of Operative Findings
- •The Need for Reoperation
- •Complications that Occur in your Absence from the Hospital
- •Withdrawal of Life-Sustaining Measures
- •Discussing the Pathology Report
- •Discussion of Long-term Survival Prospect
- •Management of the Difficult Family
- •References
- •Index

174 J. Shindoh and J.-N. Vauthey
S2/3
S1
Right + Seg 4 PVE
Pre-PVE FLR (Seg1-3)
10% vs. Total Liver Volume
Fig. 17.4 Regeneration of the future liver remnant ( FLR) after right + segment IV portal vein embolization ( PVE).
Seg segment, S segment
Portal Vein Embolization
IV portal vein [24, 25] have been recommended.
Post-PVE FLR (Seg 1-3)
33% vs. Total Liver Volume
S2/3
S1
Our previous work comparing right PVE with
Portal vein embolization (PVE) is a safe, minimally invasive procedure in which the portal
branches of the side of the liver to be resected
are embolized, leading to atrophy of the side of
the liver to be resected and compensatory hypertrophy of the FLR [17− 19]. PVE should be con-
sidered if pretreatment measurement of the FLR
(Fig. 17.1) shows insufficient FLR volume.
Several studies have demonstrated the efficacy
of PVE in terms of hepatic functional shift from
the embolized liver to the FLR and reduction of
surgical risk. First, dynamic functional shift from
the embolized liver to the FLR after PVE was
confirmed by three studies using indocyanine
green excretion rate [20], technetium Tc- 99m
galactosyl human serum albumin scintigraphy
[21], and bile clearance [22]. These three studies
indicated that PVE produced a clear functional
shift from the embolized liver to the nonembolized FLR with a concomitant increase in FLR
volume. In addition, another study showed that
when patients achieved sufficient growth of the
FLR to meet the minimum criteria for FLR volume, operative risk was significantly reduced
compared to the risk in patients who did not
meet the minimum criteria for FLR volume after
PVE [5]. To maximize regeneration of the FLR
after PVE, optimal selection of embolic materials [23] and concurrent embolization of segment
and without segment IV embolization revealed a
significantly greater increase in volume in segments II + III with segment IV embolization (median increase, 26 vs. 54 %; p = 0.021) (Fig. 17.4).
Post-PVE sFLR is a sensitive predictor of
PHI. In addition, Ribero et al. reported that degree of hypertrophy in the sFLR after PVE is
significantly associated with surgical outcomes
[26]. Degree of hypertrophy greater than 5 %
after PVE along with sFLR greater than 20 %
predicted good postoperative outcomes with high
specificity and sensitivity in patients with normal
liver function. Our group has recently found that
kinetic growth rate, defined as the degree of hypertrophy at initial volume assessment divided
by the number of weeks elapsed between PVE
and initial volume assessment, further predicted
the risk of PHI. Kinetic growth rate greater than
2.0 % per week is strongly associated with a low
risk of postoperative morbidity and mortality irrespective of the sFLR (Fig. 17.5) [27].
Recently, a European group reported safety
and efficacy data for a short-interval, two-stage
liver surgery technique consisting of an initial
open right portal vein ligation with in situ splitting of the liver parenchyma followed by reexploration for right trisectionectomy, termed
“associating liver partition and portal vein ligation for staged hepatectomy” or “ALPPS” [28].

17517 Postoperative Hepatic Insufficiency
Fig. 17.5 Examples of the clinical utility of kinetic
growth rate (KGR). All patients had standardized future
liver remnant ( sFLR) ≥ 30 % and degree of hypertrophy
(DH) ≥ 7.5 % (suggested eligibility criteria for resection);
however, KGR was a more accurate predictor of outcome.
A/B: Findings in a 60-year-old man. a On the basis of the
initial computed tomography (CT) scan, sFLR was estimated at 9 %. b Final CT 35 days after right portal vein
embolization (PVE) extended to segment IV indicated an
sFLR of 33 %, DH of 24 %, and KGR of 4.8 % per week.
The patient had an uneventful postoperative course. C/D:
Findings in a 37-year-old woman. c On the basis of the
The combination of portal vein ligation and in
situ splitting of the liver to prevent crossportal
circulation between the lobes of the liver was
believed to lead to profound hypertrophy of the
FLR. However, preliminary data suggested that
this new procedure was associated with a high
initial CT scan, sFLR was estimated at 15 %. d Final CT
35 days after right PVE extended to segment IV indicated
an sFLR of 30 %, DH of 15 %, and KGR of 3.0 % per
week. The patient had an uneventful postoperative course.
E/F: Findings in a 43-year-old man. e On the basis of the
initial CT scan, sFLR was estimated at 23 %. f Final CT
70 days after right PVE extended to segment IV (required
additional waiting time to attain adequate remnant volume) indicated an sFLR of 31 %, DH of 8 %, and KGR
of 0.3 % per week (determined after the first CT 28 days
after PVE). The patient died of postoperative liver failure.
(Source: Reprinted with permission [27] ©Elsevier 2013)
incidence of major morbidity (40 %) and inpatient mortality (12 %). The true efficacy of
ALPPS in the prevention of PHI remains controversial, and this procedure should be considered
investigational at this time.

176 J. Shindoh and J.-N. Vauthey
Limiting the Duration of Preoperative Chemotherapy
Longer duration of chemotherapy has been correlated with higher risk of liver damage, as mentioned previously [6]. We previously showed
that prolonged chemotherapy did not improve
the response rate but did increase the risk of PHI
among patients with colorectal liver metastases
[8]. In a recent study investigating the relationship between duration of chemotherapy and the
incidence of PHI according to FLR volume, we
have shown that short-duration modern chemotherapy (up to 3
without biologic agents does not increase the risk
of PHI even
%), whereas when
20−30
tory of prolonged chemotherapy prior to surgery,
sFLR should be at least 30
duration of preoperative chemotherapy should be
minimized among patients with potentially resectable colorectal liver metastases.
months or six cycles) with or
in patients with marginal sFLR (i.e.,
the patient has a his-
% [29]. Therefore,
the
Treatment of PHI
Because clinical manifestations and severity of
PHI or liver failure vary considerably from patient to patient, treatment for PHI or liver failure should be individualized according to the
patient’s degree of functional disturbance with
respect to circulation, renal function, pulmonary
function, coagulation, and mental status influenced by hyperammonemia. Plasma exchange
with or without continuous hemodiafiltration is
the only effective therapy for patients suffering
from severe liver failure, though whether this
therapy improves survival has not been established [30]. For selected patients, rescue liver
transplantation is another option. However, comorbid conditions and underlying malignant disease (even if it is resected) frequently preclude
rescue liver transplantation. In addition, given
the chronic shortage of liver donors, it is not ethical to perform extensive hepatectomy in a patient
with a high risk of PHI or liver failure and assume
that rescue liver transplantation will be an option
if serious complications occur. Preoperative risk
assessment and prevention of PHI are paramount
in the current extensive surgical approach to hepatobiliary malignancies.
Conclusion
The risk of postoperative mortality due to liver
failure is inversely associated with the quality of the underlying liver parenchyma and the
volume of the FLR. The risk of PHI, which is
a strong predictor of liver-related death, should
be assessed by routine systematic volumetry in
patients for whom major hepatectomy is being
considered. If pretreatment measurement of the
FLR shows insufficient FLR volume, adequate
preoperative management including PVE should
be added to avoid preventable morbidity or mortality after extensive hepatobiliary surgery.
Key Points
1. Postoperative serum peak bilirubin level of
greater than 7.0 mg/dL is a simple and reliable
definition of PHI, predicting morbidity and
death from liver failure with high sensitivity
and specificity.
2. FLR volume is a strong predictor of PHI and
death from liver failure. The minimum FLR
volume required should be determined ac-
cording to the quality of the underlying liver
parenchyma.
3. PVE is a safe and minimally invasive proce-
dure that results in hypertrophy of the FLR
and decreases the risk of PHI. PVE should be
considered for patients with insufficient FLR
volume.
4. Prolonged preoperative chemotherapy
( > 3 months) is associated with increased risk
of PHI. The possibility of liver damage should
be carefully considered in patients with a
history of prolonged chemotherapy prior to
surgery. Biopsy of the nontumorous liver pa-
renchyma should be considered in selected
patients.
5. Because of the limited availability of effec-
tive treatment for severe liver dysfunction,

17717 Postoperative Hepatic Insufficiency
prevention of PHI using systematic volumetry
and adequate preoperative management is
paramount in the surgical approach to hepatobiliary malignancies.
References
1. Rahbari NN, Weitz J, Hohenberger W, et al. Definition and grading of anastomotic leakage following
anterior resection of the rectum: a proposal by the
International Study Group of Rectal Cancer. Surgery.
2010;147:339–51.
2. Balzan S, Belghiti J, Far
criteria”
tor of liver failure and death after hepatectomy. Ann
Surg. 2005;242:824–8.
3. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insuf
ficiency and mortality in 1059 noncirrhotic patients
undergoing major hepatectomy. J Am Coll Surg.
2007;204:854–62.
4. Vauthey JN, Abdalla
face area
in Western adults. Liver Transpl. 2002;8:233–40.
5. Kishi Y,
and
evaluation of outcome based on systematic liver
volumetry. Ann Surg. 2009;250:540–8.
6. Shindoh J, Tzeng CW
future liver remnan
sive preoperative chemotherapy for colorectal liver
metastases. Ann Surg Oncol. 2013;20:2493–500.
7. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic
as a guide to decision-making in resectional surgery
for hepatic tumors. Hepatology. 1997;26:1176–81.
8. Kishi Y, Zorzi D, Contreras CM, et al. Extended
preoperative chemotherapy does not improve patho
logic response and increases postoperative liver
insufficiency after hepatic resection for colorectal
liver metastases. Ann Surg Oncol. 2010;17:2870–6.
9. Rubbia-Brandt L, Audard
hepatic sinusoidal
platin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–6.
Vauthey JN, Pawlik
10.
apy regimen predic
in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–72.
Abdalla EK, Denys A, Chevalier
11.
Vauthey JN. Total and segmental liver volume
variations: implications for liver surgery. Surgery.
2004;135:404–10.
Maema A, Imamura H,
12.
volume regeneration of split livers with partial
venous disruption: a latent
transplantation. Transplantation. 2002;73:765–9.
on postoperative day 5: an accurate predic-
and body weight predict total liver volume
Abdalla EK, Chun YS, et
one consecutive extended right hepatectomies:
ges O, et
EK, Doherty DA, et
, Aloia TA, et
t in patients treated with exten-
V, Sartoretti P, et
obstruction associated with oxali-
TM, Ribero D, et
ts steatohepatitis and an increase
Takayama T, et
al. The “50–50
al. Body sur-
al. Three hundred
al. Optimal
functional reserve
al. Severe
al. Chemother-
P, Nemr RA,
al. Impaired
problem in partial liver
Shindoh J, Satou S, Aoki
13.
in asymmetric
anatomical model in liver surgery. Hepatogastroenterology. 2012;59:519–25.
Kawaguchi Y, Ishizawa
14.
uptake function in veno-occlusive regions evaluated
by real-time
green. J Hepatol. 2013;58:247–53.
Mise Y, Hasegawa K, Satou S, et al. V
15.
reconstruction based on virtual liver resection to
avoid congestion in the liver remnant. Br J Surg.
2011;98:1742–51.
16. Mise Y, Tani K, Aoki T, et al. Virtual liver resection:
computer-assisted operation planning using a threedimensional liver representation. J Hepatobiliary
Pancreat Sci. 2013;20:157–64.
Abulkhir A, Limongelli P
17.
tive portal vein embolization
tion: a meta-analysis. Ann Surg. 2008;247:49–57.
Giraudo G, Greget M, Oussoultzoglou
18.
Bachellier P, Jaeck D. Preoperative contralateral por-
tal vein embolization before major hepatic resection
is a safe and efficient procedure: a large single institution experience. Surgery. 2008;143:476–82.
Mueller L, Hillert C, Moller L, Krupski-Berdien G,
19.
Rogiers X, Broering DC. Major hepatectomy for
colorectal
sion an oncological risk factor? Ann Surg Oncol.
2008;15:1908–17.
Uesaka K, Nimura Y, Nagino M. Changes in hepatic
20.
lobar
function after right portal vein embolization. An
appraisal by biliary indocyanine green excretion. Ann
Surg. 1996;223:77–83.
Hirai I, Kimura W
21.
uation of preoperative portal embolization for safe
hepatectomy, with special reference to assessment
of nonembolized lobe function with 99mTc-GSA
SPECT scintigraphy. Surgery. 2003;133:495–506.
Ijichi M, Makuuchi M, Imamura H, Takayama
22.
Portal embolization relieves persistent jaundice after
complete biliary drainage. Surgery. 2001;130:116–8.
Madoff DC, Abdalla
23.
ipsilateral
segment IV: improving hypertrophy and resection
outcomes with spherical particles and coils. J Vasc
Interv Radiol. 2005;16:215–25.
Kishi Y, Madof
24.
tion of segment 4 portal veins before extended right
hepatectomy justified? Surgery. 2008;144:744–51.
Nagino M, Kamiya J, Kanai M, et al. Right triseg-
25.
ment portal vein embolization
cinoma: technique and clinical utility. Surgery.
2000;127:155–60.
Ribero D, Abdalla
26.
Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on
regeneration, resectability and outcome. Br J Surg.
2007;94:1386–94.
morphology: significance of Hjortsjo’s
fluorescent imaging using indocyanine
metastases: is preoperative portal occlu-
, Fuse A, Suto K, Urayama M. Eval-
EK, Gupta S, et
right portal vein embolization extended to
f DC, Abdalla EK, et
EK, Madoff DC, Donadon M,
al. Hidden symmetry
T, et
T, Miyata Y, et
, Healey AJ, et
for major liver resec-
al. Preopera-
al. Transhepatic
al. Is emboliza-
for biliary tract car-
al. Portal
E, Rosso E,
enous
T.

178 J. Shindoh and J.-N. Vauthey
27. Shindoh J, Truty MJ, Aloia TA, et al. Kinetic growth
rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality
in patients with colorectal liver metastases and small
future liver remnant. J Am Coll Surg. 2013;216:201–9.
28.
Schnitzbauer AA, Lang SA, Goessmann H, et al.
Right portal vein ligation combined with in situ split
ting induces rapid left lateral liver lobe hypertrophy
enabling 2-staged extended right hepatic resection in
small-for-size settings. Ann Surg. 2012;255:405–14.
29.
Shindoh J, Andreou A,
invasion does not predict long-term
tocellular carcinoma up to 2
staging system for solitary tumors. Ann Surg Oncol.
2013;20:1223–9.
Aloia TA, et
cm: reappraisal
al. Microvascular
survival in hepa-
of the
30.
Onodera K, Sakata H, Yonekawa M, Kawamura
Artificial liver support at present and in the future. J
Artif Organs. 2006;9:17–28.
31.
van den Broek MA, Olde Damink SW, Dejong CH,
al. Liver failure after partial hepatic resection: defi-
et
nition, pathophysiology, risk factors and treatment.
Liver Int. 2008;28:767–80.
-
32.
Azoulay D, Castaing D, Smail
V, Laurent A, Lemoine A, Bismuth H. Resection of
nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann
Surg. 2000;231(4):480–6.
A, Adam R, Cailliez
A.

Biliary Leaks and Thoracobiliary Fistula
Kengo Asai and David M. Nagorney
18
Introduction
The potential for a biliary leak and fistula exists
whenever procedures are performed on the biliary tract. These procedures include a wide range
of operations that may be performed by the general or hepatopancreaticobiliary surgeon. Laparoscopic cholecystectomies to more complex
procedures such as liver and bile duct resections
and pancreaticoduodenectomy all have an associated risk of biliary leakage. A persistent biliary
leak can be a significant source of postoperative
morbidity, has been associated with increased
mortality, and in the setting of malignancy may
affect survival. Thus, an understanding of the risk
factors, diagnosis, prevention, and management
of biliary leaks is relevant for any surgeon undertaking procedures of the biliary tract.
D. M. Nagorney () · K. Asai
Department of Surgery, Division of Subspecialty General
Surgery, Mayo Clinic, 200 First Street SW, Rochester,
MN 55905, USA
e-mail: nagorney.david@mayo.edu
K. Asai
e-mail: asai.kengo@mayo.edu
Definitions
Biliary Leak and Grading System
Multiple definitions of a postoperative biliary
leak exist in the literature. Most definitions of
biliary leak require a measured volume of bilious output, typically ranging from 20 to 50 mL/
day, or a concentration of bilirubin, ranging from
5 to 20 mg/dL, in the drain effluent [1]. Drainage from a biloma (contained) or bile peritonitis (uncontained) is also consistent with a biliary
leak. Because of the lack of a uniform definition
for biliary leak in the literature, the International Study Group of Liver Surgery (ISGLS) proposed a formal definition and grading system in
2011 [1]. The ISGLS defines a biliary leak as a
bilirubin concentration in the drain fluid at least
three-times the serum bilirubin concentration on
or after postoperative day 3. This classification
scheme is applicable to radiologic or operative
procedures for bilomas or bile peritonitis as well.
Drain volume was not included because the presence of ascites and lymphatic leaks confounds accurate measurement. However, most authors suggest a volume of output greater than 100–200 cc/
day as sufficient to warrant intervention [2].
The ISGLS also proposed a grading system to
stratify the severity of the biliary leak. Grade A
biliary leaks do not affect clinical management
(Table 18.1). Grade B biliary leaks require active
therapeutic intervention either radiographically
or endoscopically, and Grade C biliary leaks require operative intervention. Biliary leaks may
T. M. Pawlik et al. (eds.), Gastrointestinal Surgery, DOI 10.1007/978-1-4939-2223-9_18,
© Springer Science+Business Media New York 2015
179

180 K. Asai and D. M. Nagorney
Table 18.1 ISGLS biliary leak grading system
Grade Change in clinical management
A No or minimal
B Radiographic or endoscopic intervention or Grade A for
C Operative intervention
Biliary leak defined as bilirubin concentration 3 × serum bilirubin on or after postoperative day 3 or if procedure performed to manage leak
ISGLS International Study Group of Livery Sur
gery
1 week
>
resolve or persist. Uncontained or persistent biliary leaks that require additional intervention to
control are labeled Grade B or C. A precise definition for persistent bile leak has not been established. However, the ISGLS classified a biliary
leak that persists for > 1 week as Grade B. Given
its relatively recent publication, the proposed
definitions and grading system of a biliary leak
have not been validated widely.
Controlled and Uncontrolled Biliary Leaks
A controlled biliary leak occurs when there is
no communication with an intraperitoneal collection. In contrast, an uncontrolled biliary leak
communicates with an intraperitoneal collection
or flows freely throughout the peritoneal cavity.
An uncontrolled biliary leak generally requires
further drainage or manipulation of extant drains
to establish control and prevent secondary infection.
Source
The source of the biliary leak can either arise
from an incomplete division or disrupted side
branch of the involved duct that is contiguous or
communicates with that duct distally or a complete division of the involved duct that becomes
discontiguous and does not communicate with
that duct distally. The former sources are likely
to resolve without operative intervention while
the latter typically require such intervention. Discontiguous ductal injuries from an entire liver
segment or more that lack communication with
the central biliary tree are also termed excluded
or orphan leaks [3]. These biliary leaks generally
persist because the parenchyma harboring that
duct maintains its vascularity. A classic example
of this biliary leak would be a divided right segmental or sectional biliary duct after laparoscopic
cholecystectomy. Regardless, the source of the
biliary leak has implications on its diagnosis and
management.
Risk Factors and Prevention
Risk factors and prevention of biliary leaks from
the extrahepatic biliary system during laparoscopic cholecystectomy and bilioenteric anastomoses will be followed by discussion of bile
leaks following hepatic resection.
Biliary leaks after laparoscopic cholecystectomy is estimated at 0.3–0.5 % [4]. Given the large
number of cholecystectomies performed annually, this operation is associated most commonly
with biliary leaks. The cystic duct stump, ducts
of Luschka, other ducts in the gallbladder fossa,
and major extrahepatic bile ducts comprise the
potential sites of biliary leakage. The cystic duct
stump represents the most common site of leak
and reported risk factors include emergency surgery, incomplete or disrupted closure of the cystic duct, width and degree of inflammation of the
cystic duct, and presence of common bile duct
stones [5, 6]. The risk factors for biliary leaks
related to major bile duct injury and classification of biliary injury following cholecystectomy
have been reported previously and a complete
discussion is beyond the scope of this chapter
[7]. Commonly cited factors include operator
inexperience and technical errors, inflammation,
and most importantly anatomic misidentification
of the extrahepatic bile duct.

18118 Biliary Leaks and Thoracobiliary Fistula
Prevention
To prevent cystic duct stump leaks, one must ensure the cystic duct stump is appropriately identified and secured. A variety of methods of securing the cystic duct stump have been described.
These include use of titanium clips, locking clips,
harmonic scalpel, suture ligature, and endovascular stapling devices. There is no evidence-based
data to suggest that any one method is vastly
superior. The technique used should ensure that
the clip or device is securely fastened, will not
be dislodged, and should span the entire cystic
duct. The cystic duct wall must be vascularized
and free of significant inflammation. For a wide
cystic duct, additional clips, ligature, or an endovascular stapler may be used after confirming the
anatomy. Cautery injury proximal to the site of
ligation should be avoided by careful dissection
and use of cautery. Gentle traction should be used
to avoid avulsion of the cystic duct from the common hepatic duct. Leakage from ducts of Luschka or from the fossa is likely related to dissection into the liver parenchyma. Efforts to stay in
the correct plane and ligation of accessory ducts
entering the gallbladder from the fossa should
decrease peripheral biliary leaks. Preventing biliary leaks from major bile duct injuries requires
correct identification of the anatomy. The critical
view of safety in which the cystic duct and cystic
artery are isolated and the cystic plate is exposed
has been shown to decrease the rate of major
biliary injuries [8]. The role of routine cholangiography to prevent injury is controversial [9].
Clearly cholangiography can define anatomy and
unsuspected injury intraoperatively. Selective intraoperative cholangiography based on operative
conditions and lack of anatomic clarity is utilized
most frequently but such use does not address
misidentification errors.
Risk Factors for Bile Leaks After Extrahepatic Bilioenteric Anastomosis
Excluding the transplant population, few studies have investigated risk factors for biliary
leaks after bilioenteric anastomoses. Biliary
reconstruction to the small bowel is undertaken
through Roux-en-Y hepaticojejunostomy or hepatico- or choledochoduodenostomy. Typically,
Roux-en-Y hepaticojejunostomy is favored because anastomotic leaks actually represent a pure
biliary fistula as reflux of enteric content through
the fistula is rare with appropriate length of
construction of the Roux limb. In contrast, biliary anastomoses to the duodenum are not pure
biliary fistulae because gastroduodenal contents
are constantly exposed to the fistula site and
comprise part of the effluent. The volume and
contents of the effluent from these biliary leaks
likely contribute to their severity. Roux-en-Y hepaticojejunostomy is the most versatile biliary
reconstruction method. It can be used in any operation after transection of the extrahepatic bile
duct. In a review of 519 hepaticojejunostomies
performed for a wide range of indications including pancreatic cancer, chronic pancreatitis, cholangiocarcinoma, and transplantation, bile leaks
occurred in 5.6 % of patients [10]. Independent
risk factors for leakage were preoperative radiochemotherapy, preoperative low cholinesterase
levels, simultaneous liver resection, and reoperation after liver transplant. Another high-volume
center reported hepaticojejunostomy leak rates of
2.2 % after pancreaticoduodenectomy [11]. The
only risk factor identified was a low preoperative
albumin.
Hepatico- or choledochoduodenostomy either
in an end-to-side or side-to-side fashion can be
used in the setting of biliary calculus, strictures,
bile duct cysts, and malignancy. Concerns about
choledochoduodenostomy include sump syndrome and potential for duodenal fistula in the
event of anastomotic leak. Sump syndrome can
occur with side-to-side choledochoduodenostomy with the accumulation of debris in the distal
blind end of the bile duct. One recent retrospective study demonstrated fewer anastomotic complications when the duodenum was used for biliary reconstruction [12] and no difference in frequency of biliary fistulae following end-to-side
choledochoduodenostomy (8 %) when compared
with Roux-en-Y jejunal reconstruction (16 %). It
should be noted, however, that Roux-en-Y was
used more frequently when the reconstruction

182 K. Asai and D. M. Nagorney
was above the confluence. In another retrospective review from India, 270 patients underwent
side-to-side choledochoduodenostomy with a
biliary leak documented in 2 % of patients [13].
Sump syndrome was not observed in any of these
patients, the majority of whom underwent preoperative endoscopic retrograde cholangiography
(ERC) and papillotomy. While retrospective,
these studies suggest the frequency of biliary
leaks may be comparable to Roux-en-Y reconstruction with low incidence of sump syndrome.
Choledochocholedochostomy is primarily
used in the setting of orthotopic liver transplantation (OLT), but has also been described in the
repair of bile duct injuries. In general, end-to-end
choledochocholedochostomy has not been favored for repair of iatrogenic bile duct injuries
given concern for subsequent stricture formation
[14]). Limited data exist to support this technique
outside of transplant. One retrospective study
comparing Roux-Y hepaticojejunostomy with
end-to-end reconstruction in 94 patients demonstrated similar rates of biliary leaks and bilomas
(10 and 7 % respectively) [15]. End–end reconstruction was used with ducts greater than 4 mm
in diameter in the absence of inflammation. With
a mean long-term follow-up of 62 months, no
significant difference in strictures was identified.
In contrast to bile duct injuries, choledochocholedochostomy is commonly used in orthotopic liver transplantation. A recent systematic
review of over 11,000 orthotopic liver transplants
documented biliary leaks in 8 % of cases [16].
The use of T-tubes to reduce biliary complications remains an area of debate. Numerous prospective randomized trials have been performed
to address this issue with conflicting results [17].
Many centers have abandoned routine use of Ttubes given the evidence from several prospective randomized trials indicating the anastomoses
can be performed with similar or lower rates of
strictures and biliary leaks. Indeed, in the systematic review by Akamatsu et al., 82 % of over
6000 deceased donor liver transplantations with
duct-to-duct anastomoses were performed without a T-tube. In contrast, many centers continue
to use splinting stents for biliary reconstruction
during live donor liver transplantation, and use of
a transcystic stent for biliary reconstruction during OLT has also been described [18].
Prevention
Specific criteria for optimal construction of bilioenteric anastomoses are sparse and techniques
vary widely. Primary recommendations for prevention of biliary leaks after bilioenteric anastomoses are (1) well-vascularized bile duct, (2) absence of cholangitis and inflammation of the bile
duct, (3) tension-free anastomosis, (4) well-vascularized duodenum or jejunum, and (5) atraumatic suture placement. For dilated bile ducts, a
single running layer of absorbable monofilament
suture is effective and efficient. For nondilated
ducts or for complex biliary anastomoses involving multiple ducts, interrupted absorbable sutures
are used. If multiple duct orifices are present,
adjacent ducts can be joined with interrupted
absorbable sutures to reduce the number of bilioenteric anastomoses. Biliary stenting to bridge
the bilioenteric anastomosis has not been shown
to reduce biliary leaks after biliary reconstruction. Stents, however, may be indicated to bridge
anastomoses after R1–2 resection to ensure biliary access for subsequent intraluminal therapy or
dilatation.
Risk Factors for Bile Leak After Liver Resection
Risk factors for biliary leak after hepatic resection have been confounded by the lack of uniform definition of biliary leak in the literature.
Several recent studies have retrospectively investigated the incidence and risk factors for biliary
leaks. In a review of 2628 consecutive resections,
preoperative jaundice, portal vein embolization,
liver resection for biliary tumors, repeat hepatectomy, extended hepatectomy, caudate resection,
two-staged resection, en bloc diaphragm resection, bile duct resection and reconstruction, longer operative duration, greater estimated blood
loss (EBL), larger tumors, portal lymph node dissection, and intraoperative transfusion were risk

18318 Biliary Leaks and Thoracobiliary Fistula
factors for biliary leak on univariable analysis
[19]. Of these factors, repeat hepatectomy, bile
duct resection, intraoperative transfusion, en bloc
diaphragm resection and extended hepatectomy
were found to be independent predictors for biliary leak on multivariable analysis. It is unclear
whether factors such as increased blood loss or
intraoperative transfusion are simply surrogates
for increased operative complexity or directly affect biliary leaks.
In another study of 505 consecutive liver resections without bile duct resection, biliary leaks
were identified in 6.7
able analysis identified
large cut surface area, and intraoperative blood
loss as independent predictors for biliary leaks
[20]. In 610 patients undergoing liver resection
without bile duct resection, peripheral cholangiocarcinoma, left hepatectomy including segment
1, transection plane outside of the main portal
scissure, and hepatectomies including the caudate or segment four were independent predictors of biliary leakage. On multivariable analysis,
peripheral cholangiocarcinoma and resection of
segment 4 were risk factors for bile leaks. Use of
fibrin glue and cirrhosis were found to decrease
the incidence of leaks [21].
Collectively, these studies suggest that complex liver resections involving the caudate, extended hepatectomy, and increased blood loss
increase the risk for biliary leak and may warrant
additional methods to assess for biliostasis intraoperatively.
% of patients. Multivari-
repeat hepatectomy, a
MA), water-jet dissection, stapling devices, and
energy devices, e.g., Ligasure (Valleylab, Tyco
Healthcare, Boulder, CO, USA), Harmonic
scalpel (Ethicon Endosurgery, Cincinnati, OH,
USA), TissueLink (Salient Surgical Technologies, Portsmouth, NH). No parenchymal transection method has been shown superior in reducing
the rate of biliary leaks. One randomized control
trial assessing the impact of parenchymal transection technique in 120 patients who were allocated
to either clamp crushing or Ligasure showed no
difference in biliary leak between groups [22]. A
retrospective analysis of 141 patients undergoing
hepatic resection without bilioenteric anastomosis compared clamp crushing, stapling, and Tissuelink with no difference in the rate of biliary
leakage [23]. Among 300 patients undergoing
stapler hepatectomy, the incidence of biliary leak
was 8 % and was claimed to be comparable to
other parenchymal transection techniques [24].
For open or laparoscopic hepatectomy, identification and stapling transection of lobar, sectional,
or segmental biliary duct provide secure closure.
Minor or intrasegmental biliary ducts are secured
with clips or suture ligature. Transection methods
should avoid trauma to the hilar ducts that can
predispose to late leaks. Laparoscopic hepatic
resections utilize the Harmonic scalpel and endovascular staplers. The former technology likely
fuses small ductules; however, conflicting data
exist on the incidence of biliary leaks ranging
from 24 to 1 % [25, 26].
Prevention of Biliary Leaks After Hepatectomy
Apart from intraoperative blood loss and transfusion, most identified risk factors are not modifiable. Techniques used to reduce intraoperative
blood loss and transfusion requirements include
use of intermittent inflow occlusion, low central venous pressure, and meticulous hemostatic
technique. A variety of parenchymal transection
techniques have been described. These include
the clamp crush, Cavitron ultrasonic surgical
aspirator (CUSA-Tyco Healthcare, Mansfield,
Intraoperative Tests for Bile Leaks
A variety of methods have been used to detect
biliary leaks intraoperatively. A simple method to
assess for biliary leaks is to place a white surgical
sponge on the cut surface to detect bile staining.
Identified sites of bile leakage are oversewn with
suture. However, this method is dependent upon
bile flow. Evacuation of bile from the biliary
ducts intraoperatively may lead to falsely negative findings. Other intraoperative biliary leak
tests utilize perfusion of the ducts. These methods include the injection of saline, methylene
blue, or indocyanine green retrograde through the
Соседние файлы в папке Библиотека им академика М.И. Перельмана
